Pulmonary Artery Hypertension
30
5
5
11
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 30 trials
100.0%
+13.5% vs benchmark
7%
2 trials in Phase 3/4
18%
2 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (30)
Sotatercept in Pulmonary Arterial Hypertension
Heart Catheterization Using Magnetic Resonance Imaging (MRI) Fluoroscopy and Passive Guidewires
Endothelial Cell Activation and Total Pulmonary Resistance in PAH
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia (FETO)
Cardiac Assessment by PV Loop in IPAH and Scleroderma PAH
: Vascular Function in Health and Disease
Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension
Vascular Subphenotypes of Lung Disease in HIV & COPD
Non-Invasive Measurements of Changes in Pulmonary Artery Pressure in Intensive Care Unit Patients Using Electrical Impedance Tomography - A Feasibility Study
Potts-shunt for the Treatment of Pediatric Patients With Severe Pulmonary Hypertension
REstoration of VItamin D in Pulmonary Arterial Hypertension
Xenon MRI in Stable Pulmonary Hypertension (Jupiter AUGEAN)
GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)
HA Residents With PVD, Pulmonary Artery Pressure (PAP) Assessed at HA (2840m) With and Without Supplemental Oxygen Therapy (SOT)
HA Residents With PVD, SDB Assessed at HA (2840m) vs LA (Sea Level)
High Altitude (HA) Residents With Pulmonary Vascular Diseases (PVD), 6 Minute Walk Distance (6MWD) Assessed at 2840m (HA) With and Without Supplemental Oxygen Therapy (SOT)
HA Residents With PVD, 6MWD Assessed at HA (2840m) vs LA (Sea Level)
Assessing the Repeatability of NT-proBNP Testing Using Laboratory and Point of Care Testing in PAH
Skeletal Muscle Mitochondrial Abnormalities and the Metabolic Syndrome in PAH
Evaluation of Respiratory Muscle in Patient With Pulmonary Arterial Hypertension